Sanofi

SanofiSanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.

www.sanofi.com

Filters
List of articles in category Sanofi
Title Published Date
Multaq® Approved in the European Union for patients with atrial fibrillation 03 December 2009
Panenza® and Humenza® Influenza A(H1N1) Vaccines Demonstrate Robust Immune Response After One Dose 09 October 2009
Multaq® (dronedarone) Recommended for Approval in the European Union 28 September 2009
Sanofi Pasteur and Butantan Institute to Provide A(H1N1) Vaccine to Brazilian Government 10 September 2009
5-year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus® Compared to NPH 13 July 2009
Sanofi-aventis to strengthen Insulin Production Capacities 10 June 2009
Update on Clopidogrel centralized applications in the European Union 02 June 2009
Sanofi-aventis introduces sanofi-aventis TV "A window on our company" 21 May 2009
Sanofi-aventis builds a New Vaccine Manufacturing Facility in France with an investment of 350 million euros 13 May 2009
Sanofi-aventis invests €100 million in new facility in Mexico 11 March 2009
INTANZA®/IDflu®, first intradermal influenza vaccine, approved in the European Union 01 March 2009
New England Journal of Medicine publishes results from the landmark ATHENA trial 18 February 2009
European Commission Clears Acquisition of Zentiva NV by sanofi-aventis 05 February 2009
Sanofi-aventis and Novozymes announce a development and commercialization collaboration 22 December 2008